MICHAEL RAMAGOS: Open Payments
NPI 1942524970 · NEW ROADS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 5 payments from 5 companies in 2025. Trend: 2023 $109 · 2024 $94 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| Dexcom, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: FREESTYLE LIBRE 3, VRAYLAR, Dexcom G6 Transmitter, REPATHA, MOUNJARO.
Industry payments across LA — which companies pay providers there.
